Cargando…

Evidence of plasma biomarkers indicating high risk of dementia in cognitively normal subjects

Subjects with comorbidities are at risk for neurodegeneration. There is a lack of a direct relationship between comorbidities and neurodegeneration. In this study, immunomagnetic reduction (IMR) assays were utilized to assay plasma Aβ(1–42) and total tau protein (T-Tau) levels in poststroke (PS, n =...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pai, Ming-Chyi, Wu, Chau-Chung, Hou, Yi-Chou, Jeng, Jiann-Shing, Tang, Sung-Chun, Lin, Wei-Che, Lu, Cheng-Hsien, Chiu, Ming-Jang, Chen, Ta-Fu, Yan, Sui-Hing, Hu, Chaur-Jong, Yang, Shieh-Yueh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786959/ https://www.ncbi.nlm.nih.gov/pubmed/35075194 http://dx.doi.org/10.1038/s41598-022-05177-z

Ejemplares similares

Assessment of High Risk for Alzheimer’s Disease Using Plasma Biomarkers in Subjects with Normal Cognition in Taiwan: A Preliminary Study
por: Hu, Chaur-Jong, et al.
Publicado: (2021)

Age-Dependent Relationship Between Plasma Aβ40 and Aβ42 and Total Tau Levels in Cognitively Normal Subjects
por: Lue, Lih-Fen, et al.
Publicado: (2019)

Corrigendum: Age-Dependent Relationship Between Plasma Aβ40 and Aβ42 and Total Tau Levels in Cognitively Normal Subjects
por: Lue, Lih-Fen, et al.
Publicado: (2019)

Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
por: Chiu, Pai-Yi, et al.
Publicado: (2022)

Analytical performance of reagent for assaying tau protein in human plasma and feasibility study screening neurodegenerative diseases
por: Yang, Shieh-Yueh, et al.
Publicado: (2017)

Elevated Plasma Level of Soluble Form of RAGE in Ischemic Stroke Patients with Dementia
por: Tang, Sung-Chun, et al.
Publicado: (2017)

Investigation of the Number of Tests Required for Assaying Plasma Biomarkers Associated with Alzheimer’s Disease Using Immunomagnetic Reduction
por: Liu, Huei-Chun, et al.
Publicado: (2021)

Time Perception in Prodromal Alzheimer's Dementia and in Prodromal Dementia With Lewy Bodies
por: Pai, Ming-Chyi, et al.
Publicado: (2021)

Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles
por: Yang, Shieh-Yueh, et al.
Publicado: (2016)

Synergistic Association between Plasma Aβ(1–42) and p-tau in Alzheimer’s Disease but Not in Parkinson’s Disease or Frontotemporal Dementia
por: Chiu, Ming-Jang, et al.
Publicado: (2021)

Visual hallucinations in Alzheimer's disease is significantly associated with clinical diagnostic features of dementia with Lewy bodies
por: Chiu, Pai-Yi, et al.
Publicado: (2017)

Complexity of Heart Rate Variability Can Predict Stroke-In-Evolution in Acute Ischemic Stroke Patients
por: Chen, Chih-Hao, et al.
Publicado: (2015)

Impact of Supratentorial Cerebral Hemorrhage on the Complexity of Heart Rate Variability in Acute Stroke
por: Chen, Chih-Hao, et al.
Publicado: (2018)

Plasma pS129-α-Synuclein Is a Surrogate Biofluid Marker of Motor Severity and Progression in Parkinson’s Disease
por: Lin, Chin-Hsien, et al.
Publicado: (2019)

Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer’s Disease
por: Yang, Shieh-Yueh, et al.
Publicado: (2017)

Stability of Plasma Amyloid-β 1–40, Amyloid-β 1–42, and Total Tau Protein over Repeated Freeze/Thaw Cycles
por: Liu, Huei-Chun, et al.
Publicado: (2020)

Development of an assay of plasma neurofilament light chain utilizing immunomagnetic reduction technology
por: Liu, Huei-Chun, et al.
Publicado: (2020)

Identification of Atrial Fibrillation by Quantitative Analyses of Fingertip Photoplethysmogram
por: Tang, Sung-Chun, et al.
Publicado: (2017)

Freezing of Speech Single Questionnaire as a Screening Tool for Cognitive Dysfunction in Patients With Dementia With Lewy Bodies
por: Chiu, Pai-Yi, et al.
Publicado: (2020)

Economic Impact of Dementia by Disease Severity: Exploring the Relationship between Stage of Dementia and Cost of Care in Taiwan
por: Ku, Li-Jung Elizabeth, et al.
Publicado: (2016)

Combined Effects of MMP-7, MMP-8 and MMP-26 on the Risk of Ischemic Stroke
por: Hsieh, Fang-I, et al.
Publicado: (2019)

Plasma α-synuclein predicts cognitive decline in Parkinson’s disease
por: Lin, Chin-Hsien, et al.
Publicado: (2017)

Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes
por: Lin, Chin-Hsien, et al.
Publicado: (2018)

Significant Association Between Low Mitochondrial DNA Content in Peripheral Blood Leukocytes and Ischemic Stroke
por: Lien, Li‐Ming, et al.
Publicado: (2017)

Synuclein Motor Dysfunction Composite Scale for the Discrimination of Dementia With Lewy Bodies From Alzheimer’s Disease
por: Chen, Ying-Tsung, et al.
Publicado: (2022)

Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer’s Dementia: Findings in Two Cohorts
por: Lue, Lih-Fen, et al.
Publicado: (2017)

Special Issue “Advanced Signal Processing in Intelligent Systems for Health Monitoring”
por: Abbod, Maysam, et al.
Publicado: (2019)

Special Issue “Advanced Signal Processing in Wearable Sensors for Health Monitoring”
por: Abbod, Maysam, et al.
Publicado: (2022)

Classifications of Neurodegenerative Disorders Using a Multiplex Blood Biomarkers-Based Machine Learning Model
por: Lin, Chin-Hsien, et al.
Publicado: (2020)

Arterial function of carotid and brachial arteries in postmenopausal vegetarians
por: Su, Ta-Chen, et al.
Publicado: (2011)

Imaging‐based pregenetic screening for NOTCH3 p.R544C mutation in ischemic stroke in Taiwan
por: Cheng, Yu‐Wen, et al.
Publicado: (2020)

The Effect of Agomelatine in Behavioral and Psychological Symptoms of Dementia
por: Wang, Carol Sheei-Meei, et al.
Publicado: (2022)

Long-Term Storage Effects on Stability of Aβ(1–40), Aβ(1–42), and Total Tau Proteins in Human Plasma Samples Measured with Immunomagnetic Reduction Assays
por: Chiu, Ming-Jang, et al.
Publicado: (2019)

Frontal variant of Alzheimer's disease with asymmetric presentation mimicking frontotemporal dementia: Case report and literature review
por: Li, Cheng‐Hsuan, et al.
Publicado: (2020)

Integrations between Autonomous Systems and Modern Computing Techniques: A Mini Review
por: Chen, Jerry, et al.
Publicado: (2019)

Pain and Stress Detection Using Wearable Sensors and Devices—A Review
por: Chen, Jerry, et al.
Publicado: (2021)

From mild cognitive impairment to subjective cognitive decline: conceptual and methodological evolution
por: Cheng, Yu-Wen, et al.
Publicado: (2017)

Association between plasma levels of hyaluronic acid and functional outcome in acute stroke patients
por: Tang, Sung-Chun, et al.
Publicado: (2014)

Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson’s disease dementia
por: Kandiah, Nagaendran, et al.
Publicado: (2017)

Operational Determination of Subjective Cognitive Decline, Mild Cognitive Impairment, and Dementia Using Sum of Boxes of the Clinical Dementia Rating Scale
por: Yang, Yu-Wan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ues9ivn5s60k5a7b5kr6nrf241